Get intelligentvalue.com

Own it today or select a payment plan

Buy Now$3,879Payment Plan$325/mo

Secured by Stripe

Premium Domain Name

intelligentvalue.com

is available for purchase

51 views

Visitors from

US 54%·

AU 32%·

IN 7%·

GB 2%·

FR 2%

Perfect for

Financial Consulting Technology Startups Educational Services Economic Forecasting E-commerce Solutions Business Analytics Artificial Intelligence Solutions Investment Advisory Strategic Planning Market Research

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

JTC Team to Host Virtual Investor Management and KOL Roundtable Event - Featuring Palisade Bio

May 03, 2022 at 07:15 AM EDT

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

- Live moderated video webcast discussion among members of the Palisade Bio management team and renowned Key Opinion Leaders on Tuesday, May 3^rd at 10:00 AM ET -

FRENCHTOWN, NJ / ACCESSWIRE / May 3, 2022 / JTC Team ("JTC"), a fully integrated corporate communications and investor relations firm, today announced it will host the Virtual Investor Management and KOL Roundtable Event - Featuring Palisade Bio on Tuesday, May 3, 2022 at 10:00 AM ET. Access the event here.

Palisade Bio is a clinical stage biopharmaceutical company advancing therapies that aid patients suffering with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. Palisade Bio's innovative lead asset LB1148, advancing toward Phase 3, is a protease inhibitor with the potential to both reduce abdominal adhesions and help restore bowel function following surgery.

Participating from the Palisade Bio management team will be Tom Hallam, Ph.D., Chief Executive Officer, Michael Dawson, M.D., Chief Medical Officer and Robert McRae, Senior Vice President, Operations and Strategic Development. Joining Palisade Bio management will be Key Opinion Leaders:

David B. Hoyt, MD, FACS, MAMSE, Emeritus Executive Director of the American College of Surgeons (ACS), Founding Member of the ACS Academy of Master Surgeon Educators™, Member of the ACS Steering Committee for the Academy, and Emeritus Professor of Surgery at the University of California, Irvine
Steven D Wexner, MD, PhD (Hon), FACS, FRCS (Eng), FRCS(Ed), FRCSI (Hon), Hon FRCS (Glasg), Director of the Digestive Disease Institute at Cleveland Clinic Florida and Chairman of the Department of Colorectal Surgery. Dr. Wexner is a paid advisor to Palisade Bio.

As part of the virtual event, Palisade Bio will discuss the importance of intestinal barrier health and how it is developing targeted therapeutics to protect and repair the integrity of the gastrointestinal tract. In addition to the moderated portion of the event, investors and interested parties will have the opportunity to submit questions. The Company will answer as many questions as possible during the event.

A live video webcast of the Virtual Investor Roundtable Event will be available here. A webcast replay will be made available shortly after the conclusion of the live event and will be accessible for 90 days.

About JTC Team

JTC is a fully integrated corporate communications firm that is dedicated to helping you tell your story to the right audiences in order to build awareness. JTC has developed a reputation of excellence for executing on robust communication strategies that deliver results. The Company partners with both public and private companies across the Life Sciences and Technology industries to help raise awareness and build stakeholder value. For more information, please visit www.jtcir.com or connect with the company on Twitter and LinkedIn.

Contact:

Jenene Thomas
JTC Team, LLC
T: +1 (833) 475-8247
jtc@jtcir.com

SOURCE: JTC Team, LLC

View source version on accesswire.com:
https://www.accesswire.com/699851/JTC-Team-to-Host-Virtual-Investor-Management-and-KOL-Roundtable-Event--Featuring-Palisade-Bio